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Abstract. 
 
Before a class II molecule can be loaded with 
antigenic material and reach the surface to engage 
 
CD4
 
1
 
 T cells, its chaperone, the class II-associated in-
variant chain (Ii), is degraded in a stepwise fashion by 
proteases in endocytic compartments. We have dis-
sected the role of cathepsin S (CatS) in the trafﬁcking 
and maturation of class II molecules by combining the 
 
use of dendritic cells (DC) from CatS
 
2
 
/
 
2
 
 mice with a 
new active site–directed probe for direct visualization 
of active CatS. Our data demonstrate that CatS is active 
along the entire endocytic route, and that cleavage of 
the lysosomal sorting signal of Ii by CatS can occur 
there in mature DC. Genetic disruption of CatS dra-
matically reduces the ﬂow of class II molecules to the 
cell surface. In CatS
 
2
 
/
 
2
 
 DC, the bulk of major histo-
compatibility complex (MHC) class II molecules is re-
tained in late endocytic compartments, although para-
doxically, surface expression of class II is largely 
unaffected. The greatly diminished but continuous ﬂow 
of class II molecules to the cell surface, in conjunction 
with their long half-life, can account for the latter ob-
servation. We conclude that in DC, CatS is a major de-
terminant in the regulation of intracellular trafﬁcking 
of MHC class II molecules.
Key words: major histocompatibility complex class II 
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T
 
lymphocytes use their antigen-specific receptors
to recognize short fragments of antigenic proteins
bound to the products of the major histocompati-
bility complex (MHC)
 
1
 
 (Germain, 1994). MHC molecules
occur in two major forms: class I products present peptides
derived predominantly from cytosolic proteins, whereas
class II products present antigenic fragments generated
largely in the endocytic pathway (Heemels and Ploegh,
1995; Wolf and Ploegh, 1995). Antigen presentation by
class II molecules relies on the confluence of their biosyn-
thetic route with the endocytic pathway, which is richly en-
dowed with proteases and other hydrolases that attack
macromolecules, to ensure that even complex particulate
matter will be converted into peptides presentable by class
II products (Demotz et al., 1989a,b; Germain, 1994; Wolf
and Ploegh, 1995; Chapman et al., 1997; Chapman, 1998).
The biosynthetic route traveled by class II molecules re-
sembles that followed by most lysosomal membrane pro-
teins (Ploegh, 1995; Pieters, 1997). The class II 
 
a
 
 and 
 
b
 
subunits are assembled onto a scaffold of a trimeric type II
membrane protein, the class II-associated invariant chain
(Ii). Ii not only serves as a chaperone to facilitate the fold-
ing and assembly of class II molecules, but also contains
the address code for their delivery to the endocytic path-
way (Bakke and Dobberstein, 1990; Lotteau et al., 1990).
The lumenal portion of Ii interacts with class II 
 
ab
 
 dimers
via a segment that binds in the peptide binding cleft, much
in the manner of an antigenic peptide (Bijlmakers et al.,
1994; Romagnoli and Germain, 1994; Ghosh et al., 1995).
In the endocytic pathway, Ii is destroyed progressively by
the combined action of cysteine and aspartyl proteases,
culminating in the generation of a short Ii fragment re-
ferred to as CLIP (Roche and Cresswell, 1991; Newcomb
and Cresswell, 1993; Maric et al., 1994; Amigorena et al.,
1995; Riese et al., 1996; Villadangos et al., 1997; Chapman,
1998). For antigen presentation to occur, this fragment
must be dislodged and exchanged for antigenic peptide in
a reaction that is catalyzed by the MHC class II–like prod-
uct, H2-DM (Denzin and Cresswell, 1995; Roche, 1995;
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1. 
 
Abbreviations used in this paper:
 
 APC, antigen-presenting cell; CatS,
 
cathepsin S; DC, dendritic cell(s); GM-CSF, granulocyte/macrophage
colony-stimulating factor; Ii, class II-associated invariant chain; LAMP,
lysosomal-associated membrane protein; LHVS, N-morpholinurea-homo-
phenylalanyl-leucyl-vinylsulfonemethyl; M6PR, mannose-6-phosphate re-
ceptor; MHC, major histocompatibility complex; PDI, protein-disulfide
isomerase; PhOH, phenol; PM, plasma membrane; PNS, postnuclear su-
pernatant(s); TfR, transferrin receptor; wt, wild-type. 
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Sloan et al., 1995; Martin et al., 1996; Miyazaki et al.,
1996). We have identified the cysteine protease cathepsin
S (CatS) as a key enzyme in the conversion of Ii into CLIP
(Riese et al., 1996, 1998; Villadangos et al., 1997; Shi et al.,
1999). Inhibition of CatS halts processing of Ii at a stage
referred to as Iip10, a fragment corresponding to the ap-
proximately NH
 
2
 
-terminal 100 residues of Ii, extending
from the very NH
 
2
 
 terminus to the COOH terminus of
CLIP (Villadangos et al., 1997; Nakagawa et al., 1999; Shi
et al., 1999).
The potency of antigen-presenting cells (APCs) to pre-
sent antigen appears to be linked both to the manner in
which they handle class II trafficking (Cella et al., 1997)
and to the sets of proteases to which newly internalized anti-
gens are exposed (Chapman, 1998). This is perhaps best
illustrated for dendritic cells (DC), the most potent profes-
sional APC. DC are now appreciated as a rather hetero-
geneous set of APCs depending on their provenance and
history of exposure to cytokines (Banchereau and Stein-
man, 1998; Lotze and Thomson, 1999). Upon their matu-
ration, DC undergo a dramatic redistribution of class II
molecules to become strong stimulators of T lymphocytes
(Cella et al., 1997; Pierre et al., 1997). The action of CatS
was suggested as an essential element in this maturation
process, because application of the CatS-selective in-
hibitor N-morpholinurea-homophenylalanyl-leucyl-vinyl-
sulfonemethyl (LHVS) arrests class II molecules in a
distribution characteristic of immature DC (Pierre and
Mellman, 1998).
The lysosomal proteases are a set of enzymes of ever in-
creasing complexity and new members of the thiol pro-
tease family with widely differing patterns of expression
continue to be discovered (Chapman et al., 1997). There-
fore, an important task is the assessment of the individual
patterns of lysosomal protease activity encountered in dis-
tinct populations of professional APCs. These activities
are relevant for maturation and trafficking of class II mol-
ecules as well as the generation of antigenic peptides from
ingested microbes or soluble antigens (Chapman, 1998).
Here we resolve the complex role of CatS in the pro-
cessing and intracellular trafficking of MHC class II mole-
cules in DC by the combination of four tools: (a) the use of
CatS
 
2
 
/
 
2
 
 mice, thus eliminating the uncertainties inherent
in any pharmacological manipulation; (b) the generation
of DC by flt3 ligand treatment in vivo, which provides
functionally mature DC in sufficient quantities for immu-
nofluorescence and detailed biochemical analysis; (c) the
combination of pulse–chase experiments with a cell frac-
tionation scheme that resolves the major class II–contain-
ing endocytic compartments; and (d) the introduction of a
new radiolabeled probe that allows direct visualization of
enzymatically active CatS.
 
Materials and Methods
 
Mice
 
The CatS
 
2
 
/
 
2
 
 (Shi et al., 1999) and Ii
 
2
 
/
 
2
 
 (Viville et al., 1993) mice used here
have been described; C57BL/6 mice (Jackson Laboratories) were used as
wild-type (wt) controls. All animals were maintained under pathogen-free
conditions at the animal facilities of Harvard Medical School in compli-
ance with institutional guidelines.
 
Isolation of DC from Mice Treated with flt3 Ligand
 
Spleens were enriched in vivo with DC by stimulation with flt3 ligand
(Maraskovsky et al., 1996). CatS
 
2
 
/
 
2
 
, Ii
 
2
 
/
 
2
 
, and C57BL/6 mice were subcu-
taneously injected with 4 
 
3
 
 10
 
6
 
 flt3 ligand–secreting B16 melanoma cells
(C57BL/6 background) prepared by transfection of murine flt3 ligand
cDNA with the retroviral vector MFG (Shi et al., 1999). Spleen cells were
harvested after the tumors reached 2–3 cm in diameter, at which time the
spleens were 5–10-fold enlarged over those of untreated mice. A single-
cell suspension of whole splenocytes was resuspended in a high-density
BSA solution (4 ml per spleen) containing 10.6 g BSA (Intergen), 18.6 ml
PBS, 2.9 ml 1 N NaOH, and 6.5 ml H
 
2
 
O as described (Shi et al., 1999). Af-
ter overlaying 2 ml of ice-cold RPMI, the splenocyte/BSA solution was
centrifuged for 20 min at 9,500 
 
g
 
. About 5 
 
3
 
 10
 
7
 
 DC per spleen were re-
covered from the interface and resuspended into RPMI. The cells were
characterized by FACS using anti-B220, CD11c, CD11b, CD3, CD4, CD8,
CD86, CD80, GR-1, and I-A
 
b
 
 antibodies. The surface phenotype of these
cells, as revealed by extensive FACS analysis, did not differ significantly
from the phenotype reported for DC generated by injection of the recom-
binant cytokine (Maraskovsky et al., 1996). Although this DC population
is by no means homogenous with regard to its myeloid and/or lymphoid
phenotype, it displays a uniform phenotype with regard to MHC class II
surface expression, shows a robust antigen-presenting capacity in vitro
(Shi et al., 1999), and therefore is considered as functionally mature DC
(Maraskovsky et al., 1997; Shurin et al., 1997). Incubation of cells in either
granulocyte/macrophage colony-stimulating factor (GM-CSF) or lipo-
polysaccharide (LPS) or both for up to 8 d did not lead to an increase in
surface class II expression, and confirms the mature stage. Neither by
FACS analysis nor light microscopy did we find any evidence for a matu-
ration defect in CatS
 
2
 
/
 
2
 
 DC. To assess the purity and confirm the pheno-
type of individual DC preparations, surface expression of I-A
 
b
 
, B220, and
CD11c was analyzed routinely by FACS for each experiment. For com-
parison of morphology and subcellular distribution of 
 
b
 
-hexosaminidase,
bone marrow–derived DC were generated by culturing bone marrow cells
in GM-CSF for 6 d as described (Inaba et al., 1992). On day six, semiad-
herent clusters were isolated, purified on a 50% serum cushion, and al-
lowed to mature in vitro by culturing them for 48 h.
 
Antibodies
 
N22, a hamster mAb that recognizes mouse MHC class II molecules (Met-
lay et al., 1990), was a gift from Dr. R.M. Steinman (Rockefeller Univer-
sity, New York, NY). The rabbit antiserum raised against the NH
 
2
 
-termi-
nal and the COOH-terminal regions of Ii (JV5: anti–NH
 
2
 
 terminus, Ii
1–29; JV11: anti–COOH terminus, Ii 156–190) as well as the rabbit antise-
rum against murine protein-disulfide isomerase (PDI) were generated in
our laboratory using standard techniques. Murine MHC class I molecules
were retrieved with the p8 antiserum. Antibodies against murine transfer-
rin receptor (TfR), LAMP-1 as well as fluorochrome-labeled antibodies
against murine I-A
 
b
 
, B220, CD80, CD86, CD11b, CD11c, CD8, and GR-1
were purchased from PharMingen. The rabbit antiserum against man-
nose-6-phosphate receptor (M6PR) was a gift from K.V. Figura (Max
Planck Institute, Gottingen, Germany), the H2-DM antiserum was kindly
provided by P. Pierre and I. Mellman (Yale University, New Haven, CT).
 
FACS Analysis
 
Single-cell suspensions were incubated for 30 min at 4
 
8
 
C with the appro-
priate conjugated antibodies in the presence of Fc Block (PharMingen),
washed, and analyzed immediately on a FACScan (Becton Dickinson) us-
ing Cell Quest software.
 
Immunofluorescence
 
Freshly isolated cells (5 
 
3
 
 10
 
5
 
) were plated in each well of glass chamber
slides (Nalge Nunc International Laboratories) in complete RPMI me-
dium supplemented with 20% FCS, and incubated at 37
 
8
 
C for 1 h to allow
the cells to attach to the slide. All subsequent steps were performed at
room temperature. Cells were washed once in PBS, and fixed for 20 min in
a 3.7% solution of paraformaldehyde. After four washes in PBS, cells
were permeabilized in RPMI medium containing 10% goat serum
(GIBCO-BRL) and 0.05% saponin for 15 min. The primary and second-
ary antibody solutions were prepared in the same medium. Cells were in-
cubated with the antibodies for 30 min and then washed three times.
Slides were mounted in Aquapoly/Mount solution (Polysciences Labora-
tories) and analyzed in a Bio-Rad MRC 1024 confocal laser scanning mi- 
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croscope. The merged images were analyzed for the presence of class II–Ii
molecules in LAMP-1 or DM positive structures using the colocalization
program from Bio-Rad.
I-A
 
b
 
 molecules were detected using the Y3P antibody that recognizes
mature 
 
ab
 
 complexes and 
 
ab
 
l, mouse Ii with the rabbit antisera JV5 and
JV11. Secondary antibodies labeled with FITC were used for I-A
 
b
 
 and Ii
detection. LAMP-1 was detected using a rat mAb (PharMingen) and a
secondary antibody coupled to CY3. H2-DM was detected by the combi-
nation of rabbit anti-DM antiserum and an anti–rabbit antibody labeled
with CY3. All secondary antibodies were made in goat and purchased
from Jackson ImmunoResearch Laboratories.
 
Metabolic Labeling
 
Equal numbers of freshly prepared DC were incubated in 1 ml methio-
nine/cysteine–free medium, supplemented with 10% FCS, 2 mM 
 
L
 
-glu-
tamine, penicillin (1:1,000 dilution U/ml), and 100 mg/ml streptomycin for
30 min. Cells were either continuously labeled with 0.5 mCi/ml [
 
35
 
S]meth-
ionine/cysteine (80/20) (Dupont New England Nuclear) for 5 h or pulsed
for 30 min and chased in 15 vol of complete RPMI supplemented with
FCS, 
 
L
 
-glutamine, penicillin, and streptomycin as above for the times indi-
cated.
LHVS, synthesized as published (Palmer et al., 1995), was added to the
pulse medium 20 min before the addition of [
 
35
 
S]methionine/cysteine and
the chase medium at a final concentration of 3 nM.
 
Subcellular Fractionation
 
Subcellular fractions were prepared essentially as described for murine
B-lymphoblasts (Castellino and Germain, 1995); all steps were performed
at 4
 
8
 
C. At each timepoint, cells were washed with PBS and 0.25 M sucrose,
taken up in 2.2 ml homogenization buffer (0.25 M sucrose, 1 mM EDTA,
pH 7.4, 1 mM PMSF), homogenized by six passes in a ball-bearing homog-
enizer (10-
 
m
 
m gap), and spun at 1,000 
 
g
 
 for 10 min to obtain postnuclear
supernatants (PNS). The amounts of incorporated [
 
35
 
S]methionine/cys-
teine of the individual homogenates, as assessed by TCA precipitation,
were adjusted to identical levels of radioactivity concentration with ho-
mogenization buffer. 9 ml of a 27% Percoll (Amersham Pharmacia Bio-
tech) solution in 0.25 mM sucrose was layered on top of a 1-ml cushion of
2.5 M sucrose and overlaid with 2 ml of PNS (containing equal amounts of
total incorporated radioactivity for each individual sample as described).
After 1 h centrifugation at 34,000 
 
g
 
 (4
 
8
 
C), 1-ml fractions were collected
from the bottom of the tube. Fractions containing the low density peak of
 
b
 
-hexosaminidase activity (fractions 9 and 10) were pooled, applied to a
10% Percoll gradient, and fractionated by centrifugation as described for
the 27% gradient.
 
Characterization of Subcellular Fractions
 
For both wt or CatS
 
2
 
/
 
2
 
 mice, the first gradient (27% Percoll) yielded two
peaks of activity of the endocytic marker enzyme 
 
b
 
-hexosaminidase (high
density peak: fractions 1
 
1
 
2, referred to as peak A). To distinguish be-
tween early and late endosomal compartments, the low density peak of
the 
 
b
 
-hexosaminidase activity in the 27% Percoll gradient was applied to a
subsequent 10% Percoll density gradient. This separation resulted in a
predominant intermediate density peak of 
 
b
 
-hexosaminidase activity at
the bottom of the gradient, peak B (fractions 1
 
1
 
2 of the 10% gradient).
Peak C (fractions 11
 
1
 
12) was defined based on distribution of radioactiv-
ity, although a small amount of 
 
b
 
-hexosaminidase was detected reproduc-
ibly. This fractionation pattern, as assayed by the endocytic marker 
 
b
 
-hex-
osaminidase, was not affected by the lack of CatS.
The marker profile showed that peak A contains mature lysosomes
based on its density of 1.09 g/ml, its 
 
b
 
-hexosaminidase activity, and the
presence of the late endosomal and lysosomal marker LAMP-1. Nonlyso-
somal characteristics (the endosomal marker TfR and M6PR, the Golgi
apparatus and ER markers galactosyl transferase and PDI, respectively,
and MHC class I, which serves as a marker for surface expression) were
absent from peak A.
The intermediate density peak of the 10% Percoll gradient (peak B)
represents late endosomes (density 1.05 g/ml, positive for 
 
b
 
-hexosamini-
dase, M6PR, and LAMP-1, but negative for TfR as well as for galactosyl
transferase and PDI and MHC class I). The low density peak (peak C)
consists of a mixture of compartments, namely ER–Golgi apparatus and
early endosomes–plasma membrane (PM), in agreement with published
observations (Castellino and Germain, 1995).
 
For every fraction of each individual experiment, the distribution of the
endocytic marker 
 
b
 
-hexosaminidase activity (Mane et al., 1989), was as-
sayed as described (Rome et al., 1979). Similarly, quantification of total
incorporated radioactivity in each fraction was routinely performed from
TCA-precipitated material. Galactosyl transferase (Roth and Berger,
1982) was measured as published (Green et al., 1987). The distributions of
TFR, LAMP-1, M6PR, and PDI (Mane et al., 1989) were visualized by
Western blot using 100 
 
m
 
l of each fraction with the appropriate primary
antibody and secondary antibody conjugated to peroxidase (Santa Cruz
Biotechnology).
 
Immunoprecipitation
 
Immunoprecipitation experiments were performed as described (Vil-
ladangos et al., 1997).
 
Cell Surface Biotinylation and Immunoprecipitation
 
DC labeled in a pulse–chase experiment were washed three times in ice-
cold PBS and incubated for 30 min at room temperature in PBS contain-
ing 0.5 mg/ml NHS-Sulfo-Biotin (Pierce). For each timepoint, the biotin-
ylated cells were lysed in NP-40 lysis buffer, and class II molecules were
immunoprecipitated with the N22 antibody. Staph A pellets were resus-
pended in 50 
 
m
 
l of PBS containing 1% SDS and boiled for 10 min. 1/10 of
each precipitate was retained for later comparison with reimmunoprecipi-
tates in SDS-PAGE. 1 ml lysis buffer containing 0.1% BSA was added to
the remaining 9/10 of the precipitate. After centrifugation, the superna-
tant was precleared once, reimmunoprecipitated with streptavidin agarose
beads as above, and analyzed by SDS-PAGE and autoradiography.
 
Densitometry
 
For quantitative evaluation, autoradiographs were analyzed using a Multi-
Image Scanning Densitometer (Alpha Innotech) and the software pro-
vided by the manufacturer. Values for MHC class I, MHC class II 
 
a
 
-chain,
Figure 1. Surface expression of I-Ab molecules in wt and CatS2/2
DC. DC freshly prepared from flt3 ligand–induced wt and CatS2/2
splenocytes were stained with fluorochrome-labeled antibodies
against I-Ab (MHC class II) and CD11c. Surface expression in
the nongated live population was analyzed by FACS. 
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SDS-stable dimers, and Ii breakdown intermediates were obtained by
summing the respective background-corrected autoradiography signal
corresponding to peak A, B, or C, either relative to each other (see Fig. 5)
or in relation to the total amount of the particular species in the entire gra-
dient (Fig. 3 and Fig. 4 A).
 
Active Site–Labeling of CatS with LHVS-Phenol
 
LHVS-phenol (PhOH) was synthesized following a scheme modified
from that described (Palmer et al., 1995). 
 
125
 
I–LHVS-PhOH (obtained by
an Iodogen-catalyzed reaction) was purified further by reverse-phase
HPLC. The peak fractions of radioactivity were dried down under re-
duced pressure and resuspended in DMSO. DC were washed three times
with ice cold Hepes/RPMI. 1 
 
3
 
 10
 
6
 
 cells were lysed for 2 h at 4
 
8
 
C in 100 
 
m
 
l
lysis buffer (50 mM Tris, 5 mM MgCl
 
2
 
, 0.5% NP-40, pH 7.4). Lysates and
subcellular fraction samples (100 
 
m
 
l) were incubated with 10 nM 
 
125
 
I–
LHVS-PhOH at 37
 
8
 
C for 1 h (final DMSO concentration of 1.7–3%). La-
beling was terminated by addition of 4
 
3
 
 SDS sample buffer. The samples
were boiled before analysis by 12.5% SDS-PAGE and visualization by
fluorography.
 
Results
 
Intracellular Distribution of MHC Class II Molecules 
in Mice Lacking CatS
 
DC from CatS
 
2
 
/
 
2
 
 mice and wt controls were generated by
inoculation of the animals with flt3 ligand–secreting mela-
noma cells. Purified splenic DC were analyzed by FACS
and confocal microscopy. Cells isolated from both types of
animal consisted of 
 
z
 
80% B220
 
low
 
, CD11c
 
high
 
, MHC class
II
 
high
 
 cells and therefore were judged to be DC, whereas
the remainder were B cells and B220
 
low
 
 CD11c
 
low
 
 cells in
roughly similar numbers. These cells were used for the ex-
periments described here, and will be referred to simply as
DC. Of note, significant morphological differences were
detected when comparing flt3-induced splenic DC with
DC generated from bone marrow precursors using GM-
CSF (see Fig. 2 A). Flt3-induced DC are smaller in size
and allow poorer resolution of intracellular compartments
by microscopy. Furthermore, they show a different distri-
bution profile of the endocytic marker 
 
b
 
-hexosaminidase
when compared with bone marrow–derived DC (see be-
low).
Although class II surface expression was remarkably
similar in CatS
 
2
 
/
 
2
 
 and wt DC (Fig. 1 A), the intracellular
distribution of class II was distinct, whereas no other gross
morphological differences were detected (Fig. 2 B). We
examined the steady-state distribution of class II mole-
cules, Ii, and the late endocytic marker LAMP-1 by in-
direct immunofluorescence on freshly isolated and per-
meabilized DC. To detect class II molecules, the Y3P
antibody was used; for detection of Ii, polyclonal antisera
directed against the cytoplasmic tail of Ii (NH
 
2
 
 terminus,
JV5 antibody) or its lumenal region (COOH terminus,
JV11 antibody) were used (Fig. 2 C). The staining for total
class II molecules observed in CatS
 
2
 
/
 
2
 
 DC is considerably
enhanced compared with wt cells, suggesting that CatS ac-
tivity influences the level of intracellular class II (Fig. 2 B).
Colocalization of class II and LAMP-1 molecules showed
that the fraction of class II in late endocytic structures is
enhanced in CatS
 
2
 
/
 
2
 
 DC. A similar observation was made
when analyzing the colocalization of class II with H2-DM
molecules (Fig. 2 B), confirming the increased fraction of
class II antigens in late endocytic compartments from
CatS
 
2
 
/
 
2
 
 DC.
Similar results were obtained when using the JV5 antise-
rum directed against the NH
 
2
 
-terminal portion of Ii (Fig.
2, B and C), suggesting that class II molecules in late en-
docytic compartments of CatS
 
2
 
/
 
2
 
 DC are bound largely to
Ii fragments that have retained an intact NH
 
2
 
 terminus. To
determine if these class II–Ii complexes contain intact Ii
Figure 2. (A) Comparison of bone marrow–derived
DC and DC induced by flt3 ligand treatment. Bone
marrow–derived DC were generated by incubating
bone marrow cells for 6 d in GM-CSF and were al-
lowed to mature in culture for 48 h after purification
of DC clusters (left). Flt3 ligand–induced DC were
obtained from the spleen of mice injected with flt3
ligand–secreting melanoma cells. Both types of DC
were permeabilized, stained for LAMP-1 (red) and
class II molecules (green), and analyzed by confocal
microscopy using identical magnification. (B) Intra-
cellular localization of MHC class II, Ii, and H2-DM
molecules in wt and CatS2/2 DC. Freshly prepared
flt3 ligand–induced DC from wt (left) and CatS2/2
(right) mice were permeabilized and stained for the
late endocytic marker LAMP-1 (red, top three
rows), H2-DM (red, bottom row), and for MHC
class II or Ii (green) (top and bottom rows, Y3P anti-
body against ab dimers; second row, JV5 antiserum
detecting the NH2 terminus of Ii; third row, JV11 antiserum recognizing COOH-terminal portion of Ii). The merged image (left image)
and the image resulting from the colocalization analysis (right image) are shown for both wt and CatS2/2 DC. (C) Schematic view of Ii
and its breakdown intermediates. MHC Ii is degraded intracellularly in a stepwise fashion. Three invariant chain molecules (Ii) bind in
their trimerization region forming a homotrimer. Three ab dimers assemble onto this scaffold of an Ii trimer, which results in the non-
americ MHC class II complex (abIi)3 referred to as abp (see also Fig. 6 A). This complex is disrupted by COOH-terminal proteolytic
degradation of Ii by aspartyl and cysteine proteases including CatS, which leads to ab molecules attached to degradation intermediates
of Ii: p22, p18, and Iip10. In DC, NH2-terminal degradation of Ii is performed by CatS, which converts Iip10 into CLIP. The epitopes
recognized by the anti-Ii antisera are indicated (JV5, NH2 terminus; JV11, COOH-terminal trimerization region).The Journal of Cell Biology, Volume 147, 1999 780
Figure 3. (A) Subcellular frac-
tionation of flt3-induced DC
from CatS2/2 and wt mice. PNS
of flt3-induced DC from CatS2/2
and wt mice were fractionated
using a 27% Percoll gradient as
described, yielding the high-den-
sity peak A (left panel, fractions
1 and 2). The low-density peak
of  b-hexoaminidase activity
(fractions 9 and 10) was applied
subsequently onto a 10% Percoll
gradient (right panel) to gener-
ate peaks B (fractions 1 and 2 of
the 10% gradient) and C (frac-
tions 11 and 12 of the 10% gra-
dient). The b-hexosaminidase
activity (beta-hex) and the distri-
bution of incorporated radioac-
tivity after metabolic labeling of
the individual fractions are ex-
pressed as percentage of the to-
tal amounts retrieved from each
gradient. (B) Comparison of the
subcellular fractionation pro-
files from DC of different origin.
DC from wt mice were either
isolated from spleens after treat-
ment with flt3 ligand (flt3 DC)
or generated from bone marrow
precursors of nontreated ani-
mals (BM DC). Subcellular frac-
tions were prepared and assayed
for  b-hexosaminidase activity
and incorporated radioactivity
as in Fig. 3 A. (C) Characteriza-
tion of subcellular fractions.
Subcellular fractions were gen-
erated from flt3-induced splenic
DC of wt mice as described. The
distribution of lamp-1, M6PR,
and TfR was assessed by
Western  blot followed by densi-
tometry.Driessen et al. Trafficking of MHC Class II in Cathepsin S2/2 Mice 781
molecules, an antiserum that exclusively recognizes the
p31 and p41 Ii forms (raised against the COOH-terminal
part of Ii) (JV11; Fig. 2 C) was employed. No difference
was seen in the extent of colocalization of LAMP-1 and Ii
between wt and CatS2/2 DC (Fig. 2 B). Thus, the MHC
class II–Ii complexes that accumulate in late endocytic
structures of CatS2/2 DC must lack the COOH-terminal
portion of Ii. As shown below, results from subcellular
fractionation experiments are in agreement with this con-
clusion.
In all experiments, CatS2/2 DC showed increased
staining with Ii antibodies as compared with wt cells, in-
dicating that the total intracellular amount of Ii is en-
hanced when CatS activity is absent (Fig. 2 B). Cytofluo-
rometric analysis of CatS2/2 and wt DC using the JV11
antiserum also revealed a significant increase of intact Ii
at the surface of CatS2/2 cells (data not shown). Finally, a
stronger signal for LAMP-1 and H2-DM staining in
CatS2/2 compared with wt DC was consistently observed
(Fig. 2 B).
In conclusion, the CatS2/2 mutation leads to an accumu-
lation of class II molecules bound to Ii with an intact NH2
terminus in late endocytic compartments of mature DC.
This observation is consistent with those obtained in
LHVS-treated bone marrow–derived DC, resembles the
intracellular distribution of class II in immature DC, and is
most likely the result of incomplete cleavage of Ii in the
absence of CatS. To verify this hypothesis and to de-
termine the nature of the MHC class II–Ii complexes that
accumulate in late endocytic compartments, subcellular
fractionation experiments on CatS2/2 and wt DC were
performed.
Resolution of Three Distinct Endocytic Compartments 
in DC by a Two-Step Density Gradient
Fractionation Scheme
Immunoelectron microscopy has shown that the majority
of intracellular class II molecules in professional APC are
found in conventional late endocytic structures (Kleijmeer
et al., 1997). To resolve the major class II–containing com-
partments biochemically, DC from CatS2/2 and wt ani-
mals were labeled with [35S]methionine and subjected to
subcellular fractionation. In brief, a homogenate was pre-
pared using a ball-bearing–type homogenizer and the PNS
was fractionated by two successive Percoll gradients. The
first gradient (27% Percoll) allowed resolution of lysoso-
mal fractions. This lysosomal peak will be referred to as
peak A (Fig. 3, A and C). The unresolved material at the
top of the 27% gradient was applied to a second gradient
(10% Percoll), which yielded a high-density fraction en-
riched for late endosomes (peak B), and at low density, an
unresolved peak comprising PMs, Golgi, early endosomes,
and ER (peak C). No attempt was made to further resolve
fraction C into its individual constituents. This fraction-
ation scheme was used to characterize the subcellular dis-
tribution of CatS activity and to dissect trafficking and
maturation of class II molecules in mature DC of wt and
CatS2/2 mice.
The modest activity of b-hexosaminidase in the lysoso-
mal peak A appears to be a cell-specific trait. A direct
comparison of the distribution profile of b-hexosamini-
dase activity between wt flt3-derived splenic DC and bone
marrow–derived DC generated in GM-CSF reveals differ-
ences in the profile of the endocytic compartments for
these two cell types. While the majority of b-hexosamini-
dase activity is found in the lysosomal compartment (peak
A) in bone marrow–derived DC, this activity is distributed
more towards the late endosomal compartment (peak B)
with a relatively lesser amount in lysosomes in flt3-derived
DC (Fig. 3 B).
Trafficking and Maturation of MHC Class II Molecules 
in wt and CatS2/2 DC
Immunoprecipitations were performed with antibodies
capable of recognizing class II molecules assembled with
intact Ii as well as Ii intermediates. Assignment of Ii frag-
ments was based on their reactivity with antipeptide anti-
sera directed either against the cytoplasmic NH2 terminus
(antiserum JV5; see Fig. 2 C) or against the COOH-termi-
nal trimerization domain (antiserum JV11) in conjunction
with estimates of their molecular size and the presence or
absence of N-linked glycans. For reference purposes, we
performed subcellular fractionation on cells obtained from
Ii2/2 animals. In the absence of Ii, class II molecules as-
semble poorly and fail to be delivered efficiently to their
normal destination. For all subcellular fractionations, the
distribution of MHC class I molecules (H-2Kb) was exam-
ined as a representative protein largely excluded from
endocytic compartments and unlikely to be affected in its
intracellular trafficking by the absence of CatS. Fraction-
ation experiments were conducted either on cells labeled
continuously for 5 h (see Figs. 4 and 5) or in conjunction
with pulse–chase labeling (see Figs. 6 and 8).
Analysis of the 27% Percoll gradients revealed that class
II molecules in DC from Cat S2/2 mice are more pro-
nounced in their distribution over the lysosomal fraction
and the denser regions of the gradient than in wt DC (Fig.
4 A). Furthermore, the overall recovery of class II mole-
cules appears greater for the CatS2/2 DC than for the wt
DC, in agreement with the qualitative assessment by im-
munofluorescence (see Fig. 2 B). Class I products are re-
covered in approximately equal amounts and are distrib-
uted similarly in CatS2/2 and wt DC (Fig. 4 B). As
expected, in Ii2/2 animals few if any class II molecules are
recovered from the dense lysosomal fraction A (Fig. 4 B).
Analysis of fractions 9 and 10 obtained from the 27%
Percoll gradient on a subsequent 10% Percoll gradient
showed that in Cat S2/2 DC, class II molecules accumulate
in the late endosomal fraction with a very similar distribu-
tion to wt DC in the remaining portions of the gradient
(Fig. 5 A). The distribution and recovery of MHC class I
molecules from Cat S2/2 DC is indistinguishable from wt
cells (Fig. 5 B). As expected, class II molecules were not
recovered from late endosomal fractions of Ii2/2 DC (Fig.
5 B) (compare with both wt and CatS2/2 DC).
The immunofluorescence in conjunction with the sub-
cellular fractionation experiments showed that class II
molecules accumulate intracellularly in DC from CatS2/2
animals. The sites of intracellular accumulation are pre-
dominantly the late endosomes, and to a lesser extent, the
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class II molecules to, or the egress from, these compart-
ments in flt3-induced splenic DC.
Next, we performed pulse–chase experiments in con-
junction with the subcellular fractionation scheme out-
lined above (Fig. 6 A). The results from these experiments
not only confirmed those obtained for continuously la-
beled cells, but also allowed important additional conclu-
sions. By analysis of each of the immunoprecipitates under
fully denaturing conditions (B; boiling in SDS sample
buffer) as well as under more mildly denaturing conditions
(NB; SDS sample buffer at room temperature), processing
intermediates of Ii were recovered in a stable complex
with the ab heterodimer from different subcellular frac-
tions. The sequence of events by which Ii is removed from
class MHC class II–Ii complexes in wt and CatS2/2 DC can
thus be established.
Recovery and distribution of MHC class I molecules was
relatively constant for the different chase points and did
not differ between wt and CatS2/2 DC (Fig. 6 A and Fig. 7
A). To quantitate the class II molecules themselves, the rel-
ative distribution of the class II a chain was analyzed. This
parameter is valid because the N22 antibody used to re-
cover class II molecules recognizes an epitope on the class
II b subunit. The pattern of reactivity of N22 is generally
assumed to be conformationally sensitive and dependent
on proper heterodimer formation (Metlay et al., 1990).
After 30 min of labeling, class II molecules were visual-
ized in CatS2/2 and wt DC in peak C as SDS-stable com-
plexes of z100 kD, which represent the nonameric struc-
ture (abIi)3 referred to as abp (Fig. 6 A, pulse). At this
timepoint, almost all of the a chain carried high mannose-
type oligosaccharides as indicated by its higher mobility
compared with the mature form, which suggested that
these molecules were still located in the ER–Golgi. This
Figure 4. Steady-state distribution of MHC class II molecules after fractionation of wt and CatS2/2DC on a 27% Percoll gradient. DC
were continuously labeled for 5 h, homogenized, and PNS were fractionated over a 27% Percoll gradient. 1-ml fractions were collected
from the bottom of the tube and analyzed by immunoprecipitation, followed by boiling of the samples, 12.5% SDS-PAGE, and autora-
diography. (A) Immunoprecipitation for MHC class II dimers from DC from wt and CatS2/2 mice, using the N22 antibody (a/b: MHC
class II a/b chain; Ii: invariant chain; p22, p18, p10: breakdown intermediates of Ii of the estimated molecular weight indicated). (B)
Same subcellular fractions immunoprecipitated for MHC class I with the p8 antiserum (top and middle panels) (HC, class I heavy chain;
b2m, b-2 microglobulin). (Lower panel) Identical experiment performed with DC from Ii2/2 mice and immunoprecipitated with N22.Driessen et al. Trafficking of MHC Class II in Cathepsin S2/2 Mice 783
ab–Ii complex appeared in peak B in both cell types at
later timepoints, but the a chain was in its mature, fully
glycosylated form.
After 1 h of chase, class II molecules reached endocytic
compartments, and were transformed into z70 kD abl
complexes by COOH-terminal degradation of Ii. No differ-
ences in either the kinetics or the subcellular distribution of
abl complexes were seen between wt and CatS2/2 DC.
This suggests direct trafficking from the ER–Golgi to early
as well as late endosomes upon maturation of class II mole-
cules, and demonstrates that access of class II complexes to
late endosomes is independent of CatS activity.
Comparison of the 1 and 3 h chase points immediately
revealed the progression of class II molecules from en-
docytic compartments to the peak that includes the PM
(peak C) in wt DC, whereas in CatS2/2 DC a greater frac-
tion of class II molecules was arrested in late endocytic
fractions (Fig. 6 A, peaks A and B; and Fig. 7 B). As ex-
pected, in wt DC the accumulation of mature, peptide-
loaded class II molecules increased with time, and was
most pronounced in lysosomes (peak A) and at the cell
surface (Fig. 6 A and Fig. 7 C). The difference in intensity
between the signal retrieved for mature class II complexes
at the cell surface and its adjoining intracellular compart-
ments (late endosomes) was striking, and suggested that
none of these compartments could solely account for the
total amount of class II complexes that finally reach the
cell surface. In contradistinction, no fully mature ab–pep-
tide complexes can be detected after a 3-h chase in CatS2/2
DC (Fig. 6 A and Fig. 7 C).
Of note, the abl isoform of class II, which is converted
into class II–CLIP complexes by CatS, was detected along
the entire endocytic route in wt DC. This raised the possi-
bility that the activity of CatS might show a similar subcel-
lular distribution. We addressed this aspect by active site–
labeling of CatS, shown below.
Figure 5. Steady-state distribution of MHC class II molecules after fractionation of wt and CatS2/2 DC on consecutive 27 and 10% Per-
coll gradients. Fractions 9 and 10 from the 27% Percoll gradient (Fig. 4) were applied to the second gradient (10% Percoll) to separate
late endosomes from the remainder. 1-ml fractions were collected from the bottom of the tube and analyzed by immunoprecipitation,
followed by boiling of the samples, 12.5% SDS-PAGE, and autoradiography. (A) Immunoprecipitation with N22 for MHC class II
dimers (a/b, MHC class II a/b chain; Ii, invariant chain; p22, p18, and p10, breakdown intermediates of Ii of the estimated molecular
weight indicated). (B) Immunoprecipitation for MHC class I with the p8 antiserum from the same fractions as 5a (top and middle)
(HC, class I heavy chain; b2m, b-2 microglobulin). (Lower panel) Identical experiment performed with DC from Ii2/2 mice and immu-
noprecipitated with N22.The Journal of Cell Biology, Volume 147, 1999 784
In wt DC only the Iip10 form accumulated to easily de-
tectable levels, whereas the p22 and p18 forms of Ii were
not readily detected (Fig. 6 A and Fig. 7 D). In CatS2/2
DC, Ii intermediates were more prominent at 3 h of chase
than after 1 h. In absolute amounts, late endosomes con-
tained the largest quantities of Ii breakdown intermedi-
ates (Fig. 6 A and Fig. 7 D). Interestingly, in late endo-
somes the p22 intermediate was more abundant than
p18,  whereas in lysosomes p22 was less abundant than p18
(Fig. 6 A and Fig. 7 D). In peak C, which based on the
presence of TfR includes early endosomes, the p22 to p18
ratio was even higher than in peaks A (lysosomes) and B
(late endosomes). These findings are consistent with a pre-
cursor–product relationship for p22 and p18, where the
most likely sites of conversion are late endosomes and ly-
sosomes.
In contrast to CatS2/2 DC, only accumulation of Iip10,
but not of p22 and p18, was observed when the CatS activ-
ity in wt DC was pharmacologically inhibited by incuba-
tion with LHVS (Fig. 6 B), although conversion from abl
to abm is efficiently blocked by this inhibitor. This sug-
gests that LHVS, even at 3 nM, might not completely
block CatS activity, i.e., p22 and p18 were still degraded by
CatS in the presence of LHVS, although Iip10 did accumu-
late.
Combined, these data suggest that in CatS2/2 DC, the
maturation of class II molecules is severely compromised
due to a failure to process Ii properly. Breakdown inter-
mediates of Ii remain associated with class II molecules,
which accumulate intracellularly in late endosomes and ly-
sosomes. In view of the similar steady-state levels of class
II molecules at the cell surface of wt and CatS2/2 DC, the
flux of class II molecules from the endocytic pathway to
the cell surface must be strongly inhibited in CatS2/2 DC.
Kinetics of MHC Class II Surface Expression in wt and 
CatS2/2 DC
The surface deposition of class II molecules was measured
more directly for wt and CatS2/2 DC by performing sur-
face biotinylation in conjunction with pulse–chase analysis
(Fig. 8). Only surface-disposed radiolabeled class II mole-
cules that arrive over the course of a pulse–chase will be-
come a substrate for surface biotinylation and allow their
recovery on a streptavidin–agarose matrix. In wt DC, we
observed extensive maturation of class II molecules over a
3-h and overnight chase, as inferred from the accumula-
tion of SDS-stable, fully mature ab–peptide complexes.
Of these molecules, a fraction can be surface biotinylated,
and this fraction increased very little between the 3-h and
overnight chase timepoints. Although surface biotinyla-
tion is not quantitative, the data suggest that deposition of
class II molecules on the cell surface reached a plateau at
or shortly after 3 h of chase in wt DC. In CatS2/2 DC, we
Figure 6. (A) Subcellular distribution of MHC class II molecules
in wt and CatS2/2 DC under pulse chase-labeling conditions.
Flt3-induced DC from wt (upper panel) and CatS2/2 (lower
panel) mice were metabolically labeled with [35S]methionine/cys-
teine for 30 min (pulse) and chased for 1 and 3 h. At each time-
point, subcellular fractions A (lysosomes), B (late endosomes),
and C (early endosomes/PM and ER–Golgi) were generated as
described. Immunoprecipitation from these fractions was per-
formed with N22 (class II) and p8 (class I) at the same time. The
samples were divided into two and analyzed by 12.5% SDS-
PAGE either without (NB) or with prior boiling (B). (abp, high
molecular weight nonameric [abIi]3 complexes; abl, 70-kD SDS-
stable complex consisting of ab bound to the Ii degradation in-
termediates Ii-p10, Ii-p18, or Ii-p22; abm, mature SDS-resistant
ab dimer bound to either CLIP or peptide; HC, MHC class I
heavy chain; a, mature class II alpha chain; a0, immature a chain;
b, mature b-chain; Ii, full-length invariant chain; b0, immature
b-chain; p10/p18/p22, COOH-terminal degradation intermedi-
ates of Ii; b2m, b-2 microglobulin). (B) Effect of LHVS on the
degradation of Ii in mature wt DC. DC were metabolically la-
beled for 30 min, and chased for 0, 1, or 3 h as described, either in
the presence (1) or the absence (–) of the CatS inhibitor LHVS
at 3 nM concentration. Cell lysates were prepared without any
further subcellular fractionation steps and directly analyzed by
immunoprecipitation using the N22 antibody. After separation
by 12.5% SDS-PAGE with (B) or without prior boiling of the
samples (NB), the samples were visualized by autoradiography.Driessen et al. Trafficking of MHC Class II in Cathepsin S2/2 Mice 785
observed the accumulation of the abl complex at 3 h and
after overnight chase, whereas very little material was ac-
cessible to surface biotinylation. Therefore, the flux of
class II molecules from intracellular compartments to the
cell surface is dramatically reduced in CatS2/2 DC.
Subcellular Distribution of CatS Activity in DC
The wide subcellular distribution of substrates for CatS
(p10 in wt DC, p22, p18, and p10 in CatS2/2 DC) sug-
gested a corresponding distribution of the active enzyme
in mature DC. For direct visualization of CatS activity, we
synthesized a derivative of LHVS that carries a phenolic
substituent on the vinylsulfone moiety to allow the intro-
duction of 125I (Fig. 9 A). This compound, LHVS-PhOH,
was radiolabeled in an Iodogen-catalyzed reaction, and
purified by reverse-phase HPLC. The peak fractions of
radioactivity were used for labeling experiments. Extracts
were prepared from DC obtained either from wt or CatS2/2
animals and labeled with 125I–LHVS-PhOH. This compar-
ison immediately revealed the labeled polypeptide of z28
kD that corresponds to CatS (Fig. 9 B). LHVS-PhOH be-
haved similarly to LHVS with respect to substrate specific-
ity and affinity, as revealed by competition experiments
(data not shown). Using 125I–LHVS-PhOH significant
CatS activity was demonstrated in all three subcellular
fractions (peaks A, B, and C) of wt DC, while CatS2/2 DC
showed no detectable signal for active CatS (Fig. 9 C).
Therefore, CatS activity is not restricted to late endocytic
compartments, but is found along the entire endocytic
route in mature DC, in good agreement with the wide pH
range of CatS activity in vitro (Chapman et al., 1997). This
result is consistent with the presence of substrates of CatS
and conversion of abl into abm in all endocytic compart-
ments examined (see above).
The additional polypeptides seen in Fig. 9 C most likely
represent other cysteine proteases, as the vinyl sulfone
functionality of LHVS-PhOH is reactive toward active site
cysteines. Furthermore, not only are the mature cathep-
sins labeled with these probes, but some of their proforms
can also be decorated (Bryant R.A.R., and H.L. Ploegh,
manuscript in preparation). Some of the higher molecular
weight polypeptides are absent in the CatS2/2 sample and
may indeed correspond to proCatS, which would be in
good agreement with a localization in the Golgi–ER com-
partment represented in peak C.
The pattern of labeling appeared highly pH-dependent,
such that at near-neutral pH, excellent selectivity of label-
ing was obtained. At more acidic pH, a newly labeled spe-
cies became prominent that we could identify as CatB,
Figure 7. Quantitative assessment of trafficking and maturation
of MHC molecules in wt and CatS2/2 DC. Signals corresponding
to individual polypeptides from Fig. 6 A were quantified by den-
sitometry and plotted to assess the maturation and subcellular
distribution of MHC class II molecules in DC from wt and CatS2/2
mice. (A) Trafficking of MHC class I heavy chain in wt and
CatS2/2 DC. (B) Trafficking of total MHC class II molecules in
wt and CatS2/2 DC. The signal retrieved from the mature a-chain
in relation to the signal from total a-chain was plotted. (C) Sub-
cellular distribution of mature MHC class II complexes (abm) in
wt and CatS2/2 DC. (D) Subcellular distribution of the Ii degra-
dation intermediates p22, p18, and Iip10 in DC from wt and
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based on comparison with DC obtained from CatB2/2
mice (data not shown). We conclude that LHVS-PhOH is
a selective, but by no means uniquely specific probe for
CatS, and infer from this result that LHVS can inhibit not
only CatS, but also other thiol proteases.
Discussion
The identification of proteases involved in the degradation
of Ii in living cells has relied largely on the use of class-
specific protease inhibitors, and more recently, on the use
of mice genetically deficient in the lysosomal proteases
CatD, CatB, CatL, and CatS. Earlier work that implicated
CatB and CatD in both Ii degradation and generation of
antigenic peptides (van Noort and van der Drift, 1989;
Maric et al., 1994; Rodriguez and Diment, 1995) has been
superseded by analyses of CatB- and CatD-deficient mice
(Deussing et al., 1998). In living cells, neither protease is
essential for maturation of class II molecules or antigen
presentation. Results obtained with the inhibitor LHVS,
rather specific for CatS at low concentrations, implicated
CatS in removal of Ii (Riese et al., 1996). In the presence
of LHVS, proteolytic processing of Ii is arrested at inter-
mediate stages (Villadangos et al., 1997). As expected,
LHVS severely compromises peptide loading, as assessed
in pulse–chase experiments. Our data obtained with a ra-
diolabeled version of the LHVS analogue LHVS-PhOH
used as an active site–directed probe allowed the identifi-
cation of enzymatically active CatS, demonstrated its pres-
ence throughout the endocytic pathway, and indicated that
CatS could act on class II–associated Ii at these differ-
ent locations. Although LHVS is quite specific for CatS
at low concentrations in vitro, higher concentrations of
LHVS will readily target other thiol proteases (Bryant,
R.A.R., G.-P. Shi, H.A. Chapman, and H.L. Ploegh, unpub-
lished observations), not all of which have been identified
to date. CatS2/2–deficient mice allow the analysis of the
contribution of CatS to maturation and intracellular traf-
ficking of MHC class II independently of the use of phar-
macological inhibitors.
Whereas class II maturation has been analyzed bio-
chemically in CatS2/2 mice, the contribution of CatS to
proper trafficking of class II molecules had not been ad-
dressed in this model (Nakagawa et al., 1999; Shi et al.,
1999). However, a role for CatS in such control was made
plausible in experiments in which the trafficking of class II
products was examined in DC in the presence and absence
of LHVS (Pierre and Mellman, 1998).
DC are the most potent antigen-presenting cells de-
scribed to date and represent a rather heterogeneous set
of professional APCs that share certain characteristic fea-
tures (Banchereau and Steinman, 1998). However, bone
marrow–derived DC, as generated by incubating bone
marrow cells with GM-CSF in vitro, and flt3 ligand–
induced splenic DC used in this study, differ in size and
relative distribution of marker enzymes. Immature DC,
upon encounter with antigen, efficiently internalize and
convert the foreign material into class II–peptide com-
plexes. In response to inflammatory stimuli, presumably
coincident with acquisition of antigenic material, these DC
undergo maturation, in essence externalizing and freezing
class II–peptide complexes at the surface for maximal ex-
posure to T cells (Cella et al., 1997). These processes, pro-
posed to be at least in part under the control of CatS,
march in lockstep with migration of DC from the periph-
ery to lymph nodes, where contact with T cells occurs.
However, the low levels of class II expression on the sur-
face of immature wt DC (Cella et al., 1997), versus the
high class II expression on mature DC from CatS2/2 mice
(Nakagawa et al., 1999; this paper) is a discrepancy that
shows differential activity of CatS to be not the only major
regulating factor for surface expression of class II during
DC maturation.
Application of the inhibitor LHVS to mature DC re-
sulted in an intracellular distribution of class II molecules
highly reminiscent of that seen in immature DC. What is
the actual route taken by class II molecules in DC and
what is the step controlled by the activity of CatS? Class II
molecules reach the endocytic compartment either by in-
ternalization from the cell surface or by targeting from the
TGN, probably to the early endosomal–late endosomal
junction. The intracellular localization of CatS activity and
the site of conversion of its substrate (abl into abm) in DC
can provide important information to resolve these ques-
Figure 8. Surface labeling of MHC class II molecules in DC from
wt and CatS2/2 cells. Flt3-induced DC from wt (upper panels)
and CatS2/2 (lower panels) mice were pulsed with [35S]cysteine/
methionine for 60 min, and chased 3 h and overnight (o/n), re-
spectively. At each chase point the cell surface was biotinylated
as described. The samples were immunoprecipitated with N22 to
retrieve total cellular MHC class II. 10% of this immunoprecipi-
tate was divided into two and loaded on a SDS-PAGE without or
with prior boiling (total, NB, and B). The remaining 90% were
reimmunoprecipitated with streptavidin-agarose beads, exten-
sively washed, and analyzed on the same 12.5% SDS-PAGE af-
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tions. Using a less direct assay, CatS activity could be dem-
onstrated only in lysosomal compartments of bone mar-
row–derived DC (Pierre and Mellman, 1998). This
contrasts with the broad distribution of CatS activity ob-
served here.
CatS is active throughout the endocytic pathway, as
demonstrated both by active site–labeling of CatS and
analysis of degradation intermediates of Ii in the presence
or absence of CatS. NH2-terminal processing of Ii by CatS
occurred throughout the entire endocytic route in mature
DC, whereas COOH-terminal degradation by proteases
other than CatS appears to be restricted to nonlysosomal
compartments. In the absence of CatS, the NH2 terminus
of Ii retains a sizable fraction of class II molecules in en-
docytic compartments until it reaches lysosomes. This situ-
ation applies to DC as well as splenocytes (Driessen, C.,
unpublished observations).
The sorting event that directs class II molecules to the
cell surface in mature DC was suggested to be localized to
an early endocytic compartment, where active CatS would
cleave Ii and release the NH2-terminal sorting signal of Ii
from the class II–Ii complexes (Pierre and Mellman, 1998).
Class II molecules from that location would reach the cell
surface, bypassing later endocytic structures. Alterna-
tively, and at the other end of the spectrum, class II mole-
cules may reach the lysosomal compartment largely inde-
pendently from the activity of CatS. CatS would then
control the egress of class II molecules from lysosomes.
We envision that these two extreme possibilities would re-
sult in major differences in terms of peptide loading,
because of the distinct characteristics of the subcellular
compartments encountered by class II molecules before
reaching the cell surface in either model. While our data
are compatible with either model, they suggest that there
are major factors in addition to CatS activity that control
the trafficking of class II molecules in DC. After 3 h of
chase, we detect a substantial amount of fully mature class
II molecules in lysosomal compartments of wt DC, indicat-
ing that conversion of Iip 10 into CLIP is probably not the
rate-limiting step in directing class II to the PM.
Since  ab–peptide complexes can thus be generated
along the entire endocytic route in mature DC, they might
leave the endocytic compartment from these many loca-
tions independently rather than following a single, shared
track. The amount of mature ab–peptide material re-
trieved from the cell surface and/or early endosome frac-
tion after 3 h of chase by far exceeds that of any of its pre-
cursor forms in a single compartment at a given time. This
would support the hypothesis that class II molecules at the
surface are recruited from several subcellular compart-
ments. The sizable amount of abm retrieved from the ly-
sosomal compartment after 3 h of chase contrasts with the
smaller amount retrieved under steady-state conditions.
We suggest it represents a kinetic intermediate and simi-
larly contributes to the fraction that reaches the surface.
Delivery of class II molecules from lysosomes directly to
Figure 9. 125I–LHVS-PhOH
as a new active site–directed
probe to visualize enzymati-
cally active CatS. (A) Struc-
ture of 125I–LHVS-PhOH.
(B) DC from wt and CatS2/2
mice were labeled with 125I–
LHVS-PhOH. Active CatS
was visualized after separa-
tion on SDS-PAGE. (C)
Subcellular distribution of
active CatS. DC from wt and
CatS2/2 were subjected to
subcellular fractionation as
described (see Fig. 3 A).
Fractions 1–8 of the 27%
Percoll gradient (including
the lysosomal peak A) and
the entire 10% Percoll gradi-
ent (separating late endo-
somes [peak B] from the re-
mainder [peak C]) were
labeled with 125I–LHVS-
PhOH, separated by 12.5%
SDS-PAGE, and visualized
by autoradiography (left
panel, high-density fractions
1–8 including peak A; right
panel, 10% Percoll gradient of
the low density fractions, peak
B, and peak C; upper panel,
wild-type DC; lower panel,
CatS2/2 DC).The Journal of Cell Biology, Volume 147, 1999 788
the cell surface has been suggested (Wubbolts et al., 1996;
Thery et al., 1998). The ensuing exchange of CLIP for anti-
genic peptides necessitates an interaction with H2-DM.
Furthermore, peptide cargo directly affects intracellular
transport of class II molecules (Bryant et al., 1999). Alter-
natively, all abm may traffic to late endocytic or lysosomal
compartments before an additional signal is required to
release class II to the surface. Again, the impact of interac-
tions with accessory molecules (H2-DM, H2-DO) remains
to be assessed.
Breakdown intermediates of Ii are abundant in CatS2/2
DC. These intermediates are detected first in early en-
docytic compartments but are particularly prominent in
late endocytic compartments and lysosomes. Based on
their molecular mass and the epitopes present, as well as
the temporal relationships in the occurrence of these inter-
mediates, a precursor-product relationship was established
that could be related to their intracellular location. Iip10,
Iip22, and Iip18 accumulate in CatS2/2 DC, and therefore
are dependent on CatS activity for further processing.
They were present in different relative amounts in early
and late endocytic compartments. Whereas p22 preferen-
tially was found in early and late endosomes, the p18 form
was favored in lysosomal compartments. Therefore, the
nature of the CatS substrate(s) changes gradually along
the endocytic route. The enzyme(s) involved in conversion
of Ii into p22 and p18 have not been identified. In contrast
to CatS2/2 DC, no accumulation of Iip22 and Iip18 was
observed when CatS activity was inhibited by treatment
with LHVS in wt DC (making the limitations of the use of
this pharmacological inhibitor evident). The incomplete
block of CatS activity by LHVS, as demonstrated by this
comparison, could be explained by a possible loss of
LHVS specificity under the acidic conditions that prevail
in late endocytic compartments. Indeed, results obtained
with the radiolabeled derivative of LHVS, LHVS-PhOH,
showed excellent selectivity of label under neutral condi-
tions rapidly lost at lower pH. The predominant localiza-
tion of p18 and p22 in late endocytic compartments would
be in line with this explanation. Under normal circum-
stances, the activity of CatS presumably coincides with
that of other enzymes that attack Ii, but at present their in-
dividual contributions cannot be distinguished.
There is of course a paradox: how can the intracellular
retention of MHC class II molecules be reconciled with
unaltered levels of surface-expressed class II complexes
observed in CatS2/2 DC? This puzzle could be resolved if
the following conditions apply. First, the half-life of class
II at the cell surface must exceed by far the normal rate of
surface deposition of class II molecules. There is ample
support for this suggestion; peptide-loaded class II com-
plexes are extraordinarily stable (Neefjes and Ploegh,
1992; Cella et al., 1997; Pierre et al., 1997). Second, a ho-
meostatic mechanism that limits the number of class II
molecules that can be inserted at the cell surface might be
operative. Given sufficient time, even a slow rate of sur-
face deposition, coupled to an upper limit for the number
of class II molecules allowed at the cell surface, would re-
sult in comparable levels of surface-expressed MHC class
II. Relative to their CatS2/2 counterparts, in normal DC
any surplus of class II molecules might be destroyed, for
example in lysosomes, rather than reach the cell surface.
This suggestion is consistent with the reproducibly higher
recovery of total class II molecules from CatS2/2 DC,
whereas the recovery of class I molecules is comparable.
Proteolysis of Ii is a compound reaction that controls in-
tracellular transport of MHC class II molecules, and ulti-
mately, their loading with peptide and display at the cell
surface. Therefore, class II molecules must function not
only at the cell surface, but also in a lysosomal environ-
ment. There, the class II–associated Ii chain represents the
equivalent of a propiece that keeps MHC class II mole-
cules in an inactive form until Ii is released by proteolysis
and its remnants have been cleared from the class II pep-
tide-binding cleft by accessory proteins such as H2-DM.
Removal of Ii is a process of interest not only for its immu-
nological consequences but also because proteolytic de-
struction of Ii is one of the few examples in which proteol-
ysis controls trafficking of a surface glycoprotein. Such
controlled proteolysis appears to regulate molecular traf-
ficking and maturation of at least three other transmem-
brane proteins, the Notch receptor (Logeat et al., 1998; De
Strooper et al., 1999), the sterol regulatory element bind-
ing protein SREBP (Brown and Goldstein, 1997), and
b-amyloid precursor protein APP (De Strooper et al., 1999;
Wolfe et al., 1999). For all three of these proteins, two or
three consecutive proteolytical steps are suggested to oc-
cur in a sequential fashion, culminating in the release of an
effector molecule (in these cases a protein fragment) that
traffics from the PM to either the nucleus (Notch, SREBP)
or the extracellular environment (APP) (Chan and Jan,
1998). The proteases that perform this final cleavage and
therefore largely control the biological activity of the
cleaved substrates have not been identified. The regula-
tion of MHC class II trafficking by sequential degradation
of Ii, as unraveled using DC from CatS2/2 mice in this
study, is not unlike these models: at least two proteolytic
steps, one of which is performed by CatS, occur in a se-
quential fashion in the course of Ii degradation along the
endocytic route. This late step releases the ab–CLIP com-
plex and initiates loading with antigenic peptide to gener-
ate the biologically active entity. Unlike the known exam-
ples for the control of trafficking and maturation of
transmembrane proteins by sequential proteolysis, degra-
dation of Ii does not occur in the cytosol but in late en-
docytic compartments where multiple proteolytic enzymes
with partly overlapping functions and specificities are con-
centrated. Even in the lysosomal environment, rich in a
large selection of proteases, proteolytic enzymes afford
sufficient specificity to tightly regulate essential cellular
properties.
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